IMPLANET Reports 2023 Annual Revenue of €7.4 Million
BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans) (Paris:ALIMP), a medical...
Month: January 2024
Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S.
BERWYN, Pa.--(BUSINESS WIRE)--Amring Pharmaceuticals Inc. (Amring), a subsidiary of Nordic Group B.V. (Nordic Pharma), announces Jai G. Parekh, MD, MBA...
CitiusTech Named a Leader and a Star Performer in Everest Group’s Payer Digital Services PEAK Matrix® Assessment 2023
PRINCETON, N.J.--(BUSINESS WIRE)--#AI--CitiusTech, a leading provider of healthcare technology services, solutions, and platforms, announced that it has been positioned as...
Red Light Holland Receives Building Permit for AEM Farms 80,000 Square Foot Mushroom Farm, Adding Substantial Future Production Capacity
New multi million dollar production facility will increase AEM Farm's mushroom production output by approximately 15-18 million dollars of domestic...
Theralase(R) Provides Update on Phase II Bladder Cancer Clinical Study
TORONTO, ON / ACCESSWIRE / January 15, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ")...
SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in India
SOPHiA GENETICS technology helps advance cancer research across India SOPHiA GENETICS and Karkinos Healthcare join forces to propel cutting-edge genomic...
Burr & Forman Provides Notice of Data Security Incident
BIRMINGHAM, Ala., Jan. 14, 2024 /PRNewswire/ -- Burr & Forman LLP ("Burr & Forman"), a law firm based in Birmingham,...
Tackling the Poor Sleep Pandemic: FRENZ Brainband by Earable Neuroscience Announces Global Sales After CES 2024 Innovation Award Win
FRENZ Brainband, a pioneering AI-powered sleep wearable initially introduced as a prototype at CES 2023, is now available for global...
ZORYVE® (Roflumilast) Topical Foam, 0.3% Clears Seborrheic Dermatitis in Individuals Who Previously Reported an Inadequate Response to Topical Steroids
New subgroup analysis from STRATUM study shows that individuals with an inadequate response, contraindication, or intolerance to steroids were 3.5...
Majority of Individuals with Atopic Dermatitis Improved with Arcutis’ Roflumilast Cream 0.15% According to New Data from Phase 3 Program
Individual patient response data highlight 91.5% of individuals treated with roflumilast cream had a measurable improvement in Eczema Area and...
SOSV-backed Biotech Firm Cell BioEngines Decides New York Is the Place to Be
Cell BioEngines, Inc moves to Manhattan, New York, to leverage the city’s focus and strategic investment in biotechNEW YORK, Jan....
SunTech Launches Vet40: A Next-Gen Surgical Vital Signs Monitor for Companion Animals
The new device offers additional features for use in both the exam room and the operating room.MORRISVILLE, NC / ACCESSWIRE...
Medicenna Announces Appointment of New Auditor
TORONTO and HOUSTON, Jan. 12, 2024 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTC: MDNAF), a clinical-stage...
Defence Begins Trading on the OTCQB and Arranges Financing
Vancouver, British Columbia--(Newsfile Corp. - January 12, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), ("Defence" or...
Notice of Deficiency with Nasdaq Continued Listing Requirements
ZURICH, SWITZERLAND / ACCESSWIRE / January 12, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
Advanced Addiction Center Announces Grand Opening of New Outpatient Center on January 13, 2024
New Era in Addiction Recovery: Advanced Addiction Center to Unveil State-of-the-Art Outpatient Facility on January 13, 2024MEDFORD, MA / ACCESSWIRE...
Navix Health Selects SOBRsafe as Exclusive Alcohol Data Partner for Next-Generation Digital Healthcare Platform
First Management Software to Provide Real-Time, Integrated Alcohol Intelligence for Behavioral HealthCOSTA MESA, CA / ACCESSWIRE / January 12, 2024...
Conference Call on Report on Operations 2023
GOTHENBURG, SE / ACCESSWIRE / January 12, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Invitation to attend XVIVO's conference call regarding...
International Myeloma Foundation and the Black Swan Research Initiative Showcase Six Oral & Poster Abstracts by the iStopMM Project at the 2023 ASH Annual Meeting
iStopMM team members Thorir Einarsson Long, Jon Thorir Oskarsson, and Sæmundur Rognvaldsson are 2023 ASH Abstract Achievement AwardeesSTUDIO CITY, Calif.,...
ReWalk Robotics Expands Direct Sales Coverage to Canada
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Jan. 12, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”...